Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4566 per EA under NDC 33342010607. Its NADAC has been published 263 times since Jun 16, 2021.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB
Emtricitabine and tenofovir disoproxil fumarateStrength
200; 300 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342010607
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA203442On Market Since
5/15/2020
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has been published 263 times since Jun 16, 2021, and over the history we have for it it has declined 61.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4566 per EA |
|---|---|
| All-time high | $1.5055 (Aug 11, 2021) |
| All-time low | $0.4258 (May 22, 2024) |
| 52-week high | $0.5904 |
| 52-week low | $0.4508 |
| Median price | $0.5846 |
| Average price | $0.6366 |
| Largest weekly change | +37.3% (Jun 19, 2024) |
| Weeks tracked | 263 |
| Tracking since | Jun 16, 2021 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.4566 per EA (NDC 33342010607), effective Jun 24, 2026.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has declined 61.3%. It has been tracked across 263 weekly CMS publications since Jun 16, 2021.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
Since Jun 16, 2021, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has ranged from a low of $0.4258 (May 22, 2024) to a high of $1.5055 (Aug 11, 2021), with a median of $0.5846 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
4 NADAC-published products share the same active ingredient, strength, and dosage form as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB (NDC 33342010607) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification